YOLT-203
- Generic Name
- YOLT-203
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
Early Phase 1
Active, not recruiting
- Conditions
- Type 1 Primary Hyperoxaluria
- Interventions
- First Posted Date
- 2025-03-24
- Last Posted Date
- 2025-03-24
- Lead Sponsor
- Guangzhou Women and Children's Medical Center
- Target Recruit Count
- 2
- Registration Number
- NCT06892301
- Locations
- 🇨🇳
Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong, China
Clinical Exploration Study of YOLT-203 in the Treatment of Type 1 Primary Hyperoxaluria (PH1)
- First Posted Date
- 2024-07-19
- Last Posted Date
- 2025-05-16
- Lead Sponsor
- RenJi Hospital
- Target Recruit Count
- 21
- Registration Number
- NCT06511349
- Locations
- 🇨🇳
Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath